Fertility News and Research

RSS

RI-MUHC and McGill University teams receive $5M CIHR grant for environmental and reproductive health studies

Two teams from the Research Institute of the McGill University Health Centre (RI-MUHC) and McGill University received significant support from the Canadian Institutes of Health Research (CIHR) amounting to $5 million over five years.

15 Feb 2010

IntegraMed America prices common stock offering at $7.50 per share

IntegraMed America, Inc. today announced that it has priced a public offering of 2,500,000 shares of its common stock at a price to the public of $7.50 per share, of which 2,000,000 shares are being offered through the underwriters named below and 500,000 shares are being offered directly by IntegraMed to IAT Reinsurance Company Ltd., IntegraMed’s largest stockholder.

12 Feb 2010

Vitrolife announces 14% increase in sales for fourth-quarter 2009

Sales increased by 14 percent during the fourth quarter and amounted to SEK 67 (59) million. Calculated in local currency growth was 15 percent. Sales for the year amounted to SEK 275 (225) million, corresponding to an increase of 22 percent. Calculated in local currencies growth was 10 percent.

10 Feb 2010

New Success Prime IVF Program launched

Reproductive Partners Medical Group, Inc. announces the launch of the Success Prime IVF Program, an IVF money back guarantee for best-case patients.

10 Feb 2010

New Multi-Cycle program reduces risk of infertility treatment for older mothers

Fertility experts at the Reproductive Science Center of the Bay Area (RSC) announced they have launched a new program from IntegraMed geared toward easing the risk of infertility treatment for qualified women of ages 49 and younger who want to use their own eggs in order to achieve pregnancy.

10 Feb 2010

Physical Activity Innovations named ‘Bluetooth Innovator of the Year’ for 2009

The Bluetooth SIG has awarded Edward Sazonov, Physical Activity Innovations LLC, the title of Bluetooth Innovator of the Year for 2009. Sazonov received this recognition at the official award ceremony held in-line with the Wearable Technologies Show at ispo 2010, the world’s largest trade show for sporting goods.

9 Feb 2010

Study indicates women receiving antiretroviral therapy are more likely to become pregnant

In PLoS Medicine this week a study conducted in a multi-country HIV treatment program in sub-Saharan Africa has found that pregnancy rates increase in HIV-infected women after they start antiretroviral therapy (ART).

9 Feb 2010

Repros Therapeutics submits Androxal revised indication statement to the FDA

Repros Therapeutics Inc. today announced that the Company, as requested by the FDA during the Type C meeting held on January 25, 2010, has sent a revised indication statement to the FDA’s Division of Reproductive and Urologic Products for the use of Androxal® in the treatment of men wishing to preserve fertility while being treated for their hypogonadal state.

8 Feb 2010

IntegraMed America reports solid revenue growth for fourth-quarter and full-year 2009

IntegraMed America, Inc., the nation’s leading manager of specialty outpatient healthcare facilities in the emerging, technology-focused medical niches of fertility and vein care, today announced improved results for the fourth quarter and full-year periods ended December 31, 2009.

5 Feb 2010

Results validating performance of GSN’s proprietary Parental Support technology published

Gene Security Network, Inc (GSN) today announced that Human Reproduction published results validating the exceptional performance of GSN’s proprietary Parental SupportTM technology over existing methods to detect chromosome abnormalities during in vitro-fertilization (IVF).

5 Feb 2010

International Stem Cell opens new cell production facility in Oceanside, California

International Stem Cell Corporation, www.internationalstemcell.com, announced today that its new cell production facility has passed final building inspection, which will enable development and manufacturing of the company and its partners’ clinical-grade stem cell products.

5 Feb 2010

PROLOR Biotech reports the EC approval of Merck's ELONVA

PROLOR Biotech, Inc., (OTC Bulletin Board: PBTH) today noted the European Commission (EC) approval of Merck & Co., Inc.'s ELONVA®, a long-acting CTP-modified version of the fertility drug follicle stimulating hormone (FSH).

30 Jan 2010

Scientists discover mechanism that regulates prolactin hormone

A mechanism for regulating the hormone prolactin has newly been revealed by scientists at Karolinska Institutet. The results are to be published in the scientific journal Neuron, and may be significant for conditions and functions such as breast-feeding, sexual libido, and metabolism.

28 Jan 2010

Merck receives marketing authorization for ELONVA

Merck & Co., Inc., which operates outside the U.S. and Canada as MSD, today announced the European Commission (EC) approval of ELONVA® (corifollitropin alfa injection). ELONVA is indicated for controlled ovarian stimulation (COS) in combination with a GnRH antagonist for the development of multiple follicles in women participating in an assisted reproductive technology (ART) program.

28 Jan 2010

FDA approves FIRST RESPONSE Early Result Pregnancy Test

Church & Dwight Co., Inc. announced today that the U.S. Food and Drug Administration (FDA) has cleared the FIRST RESPONSE® Early Result Pregnancy Test which can determine pregnancy up to six days before the day of a woman's missed period

27 Jan 2010

Women with higher blood levels of PBDEs take longer to become pregnant, say researchers

Women with higher blood levels of PBDEs, a type of flame retardant commonly found in household consumer products, took longer to become pregnant compared with women who have lower PBDE levels, according to a new study by researchers at the University of California, Berkeley.

27 Jan 2010

Erbitux improves survival of mCRC patients with KRAS wild-type tumors

Merck Serono, a division of Merck KGaA, Darmstadt, Germany, today announced that Erbitux® (cetuximab) provided an improvement in overall survival (OS) when added to the standard 1st-line FOLFIRI chemotherapy regimen for metastatic colorectal cancer (mCRC) patients with KRAS wild-type tumors in the CRYSTAL study.

24 Jan 2010

Simple, five minute saliva test to determine baby's risk for more than 100 life-threatening genetic diseases

Genetic diseases like those seen in the new Harrison Ford movie "Extraordinary Measures" can now be prevented with a simple saliva test which is free with insurance for more than 100 million Americans.

22 Jan 2010

Research shows frozen human eggs are as effective as fresh eggs to preserve fertility

Fertility specialists responsible for the first pregnancy in the Pacific Northwest resulting from frozen human eggs are hailing new research showing that frozen eggs can be as effective as fresh eggs in helping previously infertile women achieve pregnancy.

22 Jan 2010

Infertility can lead to isolation and impact on couple’s relationships

Struggling to get pregnant can be a serious blow to the self-esteem of both women and men, according to a new national survey. Seven in 10 (71 percent) women said that infertility makes them feel flawed, while half of men (50 percent) say it makes them feel inadequate.

22 Jan 2010

Fertility News and Research

RI-MUHC and McGill University teams receive $5M CIHR grant for environmental and reproductive health studies

IntegraMed America prices common stock offering at $7.50 per share

Vitrolife announces 14% increase in sales for fourth-quarter 2009

New Success Prime IVF Program launched

New Multi-Cycle program reduces risk of infertility treatment for older mothers

Physical Activity Innovations named ‘Bluetooth Innovator of the Year’ for 2009

Study indicates women receiving antiretroviral therapy are more likely to become pregnant

Repros Therapeutics submits Androxal revised indication statement to the FDA

IntegraMed America reports solid revenue growth for fourth-quarter and full-year 2009

Results validating performance of GSN’s proprietary Parental Support technology published

International Stem Cell opens new cell production facility in Oceanside, California

PROLOR Biotech reports the EC approval of Merck's ELONVA

Scientists discover mechanism that regulates prolactin hormone

Merck receives marketing authorization for ELONVA

FDA approves FIRST RESPONSE Early Result Pregnancy Test

Women with higher blood levels of PBDEs take longer to become pregnant, say researchers

Erbitux improves survival of mCRC patients with KRAS wild-type tumors

Simple, five minute saliva test to determine baby's risk for more than 100 life-threatening genetic diseases

Research shows frozen human eggs are as effective as fresh eggs to preserve fertility

Infertility can lead to isolation and impact on couple’s relationships

Revolutionizing Life Science: An Interview with SCIEX on ASMS, the SCIEX 7500+ System, and AI-Driven Quantitation

From Discovery Biology to ELRIG Chair

Breathing New Life into Diagnostics: Plasmion's SICRIT Technology

Latest News